Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Stephen L Gwaltney"'
Autor:
Lei Chen, Paula Milani de Marval, Kendall Powell, Mark Johnson, Greg Falls, Brian Lawhorn, Aurélie Candi, Amuri Kilonda, Bart Vanderhoydonck, Arnaud Marchand, Matthias Versele, Georg Halder, Stephen L. Gwaltney, Adeela Kamal
Publikováno v:
Cancer Research. 83:4964-4964
Many cancers harbor mutations in the Hippo pathway that lead to constitutive activation of the transcriptional co-activators YAP/TAZ that then bind the transcription factor TEAD and drive aberrant transcription of target genes involved in cell prolif
Autor:
Adeela Kamal, Aurélie Candi, Matthias Versele, Bart Vanderhoydonck, Arnaud Marchand, Ron de Jong, Thuy Hoang, Georg Halder, Patrick Chaltin, Stephen L. Gwaltney, Mike Burgess
Publikováno v:
Cancer Research. 82:3945-3945
Background: The Hippo pathway is an evolutionarily conserved signaling cascade whose deregulation can promote excessive cell proliferation and tumor development. Pathway output is mediated by the YAP and TAZ transcriptional co-activators, which bind
Autor:
Petro Halkowycz, Zacharia Cheruvallath, Mark Sabat, Bumsup Lee, David J. Hosfield, Andrew John Jennings, Haixia Wang, Mingnam Tang, Stephen L. Gwaltney, Yiqin Wu, Charles E. Grimshaw
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 27:2678-2682
Guided by co-crystal structural information obtained from a different series we were exploring, a scaffold morphing and SBDD approach led to the discovery of the 1,4-disubstituted indazole series as a novel class of GKAs that potently activate GK in
Autor:
Athiwat Hutchaleelaha, Harris Jason R, Qing Xu, Donna Oksenberg, Matthew P. Jacobson, Carl Johnson, Larysa N. Patskovska, Zhe Li, Joyce James, Qing Lu, Paulvannan Kumar, Chihyuan Chuang, Donghong Xu, Yury Patskovsky, Lan Hua, Abel Silva-Garcia, Kobina Dufu, Brian Metcalf, Bradley P Morgan, James R. Partridge, Stephen L Gwaltney, Calvin Yee, Mira Patel, Steven C. Almo
We report the discovery of a new potent allosteric effector of sickle cell hemoglobin, GBT440 (36), that increases the affinity of hemoglobin for oxygen and consequently inhibits its polymerization when subjected to hypoxic conditions. Unlike earlier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::474bb23099c36d4a59ac8cad2e76a0d7
https://europepmc.org/articles/PMC5346980/
https://europepmc.org/articles/PMC5346980/
Autor:
Stephen L. Gwaltney, Mark Sabat, Yiqin Wu, Zacharia Cheruvallath, Bumsup Lee, Prasuna Guntupalli, David J. Hosfield, Andrew John Jennings, Jun Feng, Mingnam Tang, Joanne Miura, Haixia Wang
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:2166-2171
Guided by co-crystal structures of compounds 15, 22 and 30, an SBDD approach led to the discovery of the 6-methyl pyridone series as a novel class of GKAs that potently activate GK in enzyme and cell assays. Anti-diabetic OGTT efficacy was demonstrat
Autor:
Robert J. Skene, Stephen L. Gwaltney, Betty Lam, Lihong Shi, Jeffery A. Stafford, Zhiyuan Zhang
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 22:6628-6631
Dipeptidyl peptidase IV (DPP-4) inhibitors have been shown to enhance GLP-1 levels and thereby improve hyperglycemia in type II diabetes. From a small fragment hit, using structure-based design, we have discovered a new class of non-covalent, potent
Autor:
Christopher L. Caster, Michael B. Wallace, Rongda Xu, Daniel B. Kassel, Jun Feng, Lihong Shi, Stephen L. Gwaltney, Zhiyuan Zhang, Robert J. Skene
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 18:2362-2367
A novel series of non-covalent, benzimidazole-based inhibitors of DPP-4 has been developed from a small fragment hit using structure-based drug design. A highly versatile synthetic route was created for the development of SAR, which led to the discov
Autor:
Hing L. Sham, Russell A. Judge, Akiyo Claiborne, Thomas J. Sowin, Haiying Zhang, Stephen L. Gwaltney, Nan-Horng Lin, Kent D. Stewart, Yunsong Tong, Chang Park, Saul H. Rosenberg, Peter Kovar, Zehan Chen, Wen-Zhen Gu, Robert B. Credo
Publikováno v:
Bioorganic & Medicinal Chemistry. 15:2759-2767
A new class of checkpoint kinase 1 (CHK-1) inhibitors bearing a 1,4-dihydroindeno[1,2-c]pyrazole core was developed after initial hits from high throughput screening. The efficient hit-to-lead process was facilitated by X-ray crystallography and led
Autor:
Shi-Chung Ng, Gerard M. Sullivan, Weibo Wang, Hovis M. Imade, Stephen J. O'connor, Haiying Zhang, Hing L. Sham, Stephen L. Gwaltney, Saul H. Rosenberg, Lisa A. Hasvold, Jerome Cohen, Wen-Zhen Gu, Joy Bauch, Qun Li, Stephen K. Tahir, Steve Muchmore, Charles W. Hutchins, Kennan C. Marsh, Nelson Lissa T, Clarissa G. Jakob, Vincent S. Stoll, David Frost
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 13:1359-1362
Inhibitors of farnesyltransferase are effective against a variety of tumors in mouse models of cancer. Clinical trials to evaluate these agents in humans are ongoing. In our effort to develop new farnesyltransferase inhibitors, we have discovered a s
Autor:
Kenneth J. Barr, Laura Gehrke, Hing L. Sham, Michael A. Nukkala, Jang Lee, Shi Chung Ng, Nicolette A. Zielinski, Stephen L. Gwaltney, Michael C. Fitzgerald, Stephen K. Tahir, R. Bruce Credo, Akiyo Claiborne, Robert B. Warner, Keith W. Woods, Gang Liu, Ki H. Kim, David Frost, Yu Hua Hui, Kennan C. Marsh, Qun Li, Saul H. Rosenberg, Peter Kovar
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 12:465-469
A series of indole containing oxazolines has been discovered as a result of structural modifications of the lead compound A-105972. The compounds exert their anticancer activity through inhibition of tubulin polymerization by binding at the colchicin